Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 StudyFrançoise Huguet, Hervé Dombret, Agnès Chassevent et al.|Journal of Clinical Oncology|2009Cited by 562
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 studyAdrienne de Labarthe, Hervé Dombret, Philippe Rousselot et al.|Blood|2006Cited by 345
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemiaKheïra Beldjord, Hervé Dombret, Sylvie Chevret et al.|Blood|2014Cited by 327
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) studyVahid Asnafi, Elizabeth Macintyre, Agnès Buzyn et al.|Blood|2008Cited by 242
Long-Term Follow-Up of the Imatinib GRAAPH-2003 Study in Newly Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A GRAALL StudyAline Schmidt, Xavier Thomas, Philippe Rousselot et al.|Transplantation and Cellular Therapy|2012Cited by 149